Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Hyal and The Hospital for Sick Children vascular disease collaboration

Nov. 15, 1996

Cypros acquires well-established Rx for esophageal varices

Nov. 15, 1996

Human pharmacokinetic/pharmacodynamic studies on bosentan

Nov. 15, 1996

NEP and ECE inhibitors reported by Kali-Chemie

Nov. 15, 1996

Clinical trials update on nibentan, Russian antiarrhythmic drug

Nov. 15, 1996

Chugai discloses antiischemic agents

Nov. 15, 1996

FDA approves once-daily antihypertensive combination

Nov. 15, 1996

Biovail licenses once-daily diltiazem

Nov. 15, 1996

Endothelin antagonists claimed by E. Merck

Nov. 15, 1996

Fujisawa describes ACE and/or NEP inhibitors

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...